Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia
- 23 April 2018
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 53 (8) , 1046-1052
Abstract
Objective: Vascular endothelial growth factor (VEGF) and sphingolipid metabolites, sphingosine 1‐phosphate (S1P), and ceramides are important to lung development and repair. We hypothesized specific sphingolipid and VEGF alterations would be associated with BPD development and aimed to investigate the early tracheal aspirate (TA) VEGF and S1P relationship with later diagnosis of preterm infant bronchopulmonary dysplasia, BPD.Design: TA VEGF and lipidomics were measured in TA from Infants infants (9 NoBPD and 16 BPD) with mean gestational age of 27.8 ± 2.5 SD weeks and 25.1 ± 1.9 SD weeks respectively, P < 0.01. Later development of BPD was associated with elevated mean TA VEGF 604.3 ± 150.2 SE pg/mL versus NoBPD 120 ± 34.3 SE pg/mL, elevated S1P, 11.5 ± 2.3 SE pmol/mL versus NoBPD 4.8 ± 0.6 SE pmol/mL, and elevated selected ceramides during the first week of life.Conclusions: Airway VEGF and sphingolipid metabolites were distinctly elevated within the first days of postnatal life in preterm infants with later BPD progression. These biomarkers may be useful as indicators of lung injury development or as targets to decrease BPD risk.Keywords
Funding Information
- National Institute of Child Health and Human Development (NICHD 1R21HD059047-01A1)
This publication has 26 references indexed in Scilit:
- Fenretinide Causes Emphysema, Which Is Prevented by Sphingosine 1-PhoshatePLOS ONE, 2013
- The role of sphingolipids in respiratory diseaseTherapeutic Advances in Respiratory Disease, 2011
- Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometersJournal of Lipid Research, 2009
- Soluble Vascular Endothelial Growth Factor Receptor 1 in Tracheal Aspirate Fluid of Preterm Neonates at Birth May Be Predictive of Bronchopulmonary Dysplasia/Chronic Lung DiseasePediatrics, 2009
- Effects of Long-Term Sildenafil Treatment for Pulmonary Hypertension in Infants with Chronic Lung DiseaseThe Journal of Pediatrics, 2009
- A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell deathBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Ceramide decreases surfactant protein B gene expression via downregulation of TTF-1 DNA binding activityAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Respiratory outcome in school‐aged, very‐low‐birth‐weight children in the surfactant eraActa Paediatrica, 2004
- Peptide Growth Factors in Tracheal Aspirates of Mechanically Ventilated Preterm NeonatesPediatric Research, 2003
- Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivorsDevelopmental Medicine & Child Neurology, 2000